Home Visit
Upload
ASCA-IgA Saccharomyces Cerevisiae Serum
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Saccharomyces Cerevisiae Antibody IgA are associated with immune responses to Saccharomyces cerevisiae, a yeast commonly found in the digestive tract. Elevated levels of ASCA-IgA antibodies may indicate Crohn's disease. The ASCA-IgA (Anti-Saccharomyces Cerevisiae Antibody IgA) Serum Test is a blood test used in gastroenterology to aid in the differentiation of inflammatory bowel diseases (IBD), specifically to distinguish between ulcerative colitis and Crohn's disease. It measures the presence of ASCA-IgA antibodies, which are often associated with Crohn's disease.
ASCA-IgA Saccharomyces Cerevisiae Serum Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the ASCA-IgA Saccharomyces Cerevisiae Serum with a clear pricing structure.
The ASCA-IgA Saccharomyces Cerevisiae Serum Price in Mumbai is ₹ 2,360 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The ASCA-IgA Serum Test measures the level of Anti-Saccharomyces Cerevisiae Antibody IgA in the blood.
- Distinguishing between ulcerative colitis and Crohn's disease: Differentiating between these two forms of IBD is crucial for guiding treatment decisions, as management strategies may vary.
- In cases where the clinical presentation of IBD is ambiguous, the presence of ASCA-IgA antibodies can aid in diagnosis.
- Identifying Crohn's disease through this test can lead to more targeted treatment plans, as it may involve a different part of the gastrointestinal tract than ulcerative colitis.
The ASCA-IgA Serum Test may be recommended in the following situations:
- When distinguishing between ulcerative colitis and Crohn's disease: Patients with IBD symptoms who need a precise diagnosis to guide treatment.
- In cases of atypical or ambiguous IBD symptoms: When clinical symptoms do not clearly align with either ulcerative colitis or Crohn's disease.
- Prior to specific treatment choices: Healthcare providers may use this test to confirm the presence of Crohn's disease before prescribing treatments that are specific to this condition.
A positive result in the ASCA-IgA Serum Test, indicating elevated levels of these antibodies, suggests a higher likelihood of Crohn's disease.
The ASCA-IgA Serum Test is a standard blood draw. A healthcare provider will collect a sample of the patient's blood, typically from a vein in the arm. After that, a laboratory does the analysis on the sample.
No specific preparations are required before the ASCA-IgA test. However, you should follow the healthcare provider's instructions for blood tests.
The ASCA-IgA Serum Test is often used in conjunction with other diagnostic tests for IBD, such as:
- Imaging studies: X-rays, CT scans, or MRI scans to assess the condition of the digestive tract.
- Colonoscopy or sigmoidoscopy: Visual examinations of the colon and rectum to assess inflammation and tissue damage.
- Blood tests: Complete blood count (CBC) and other blood markers to assess inflammation and overall health.
- Anti-Saccharomyces Cerevisiae Antibody IgA Test
- Crohn's Disease Antibody Test
- IgA Antibodies to Saccharomyces Cerevisiae Test
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp